Browse the full insider trade history of Maze Therapeutics, Inc., a listed equity based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). Market capitalisation: €1.3bn. The latest transaction was reported on 3 June 2026 (Levée d'options). Among the most active insiders: Bernstein Harold. All data is free.
9
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
€1m
5 ops.
Sell Volume
42Σ signal
Buys ·€1m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.